US 12097213
Sequential treatment of cancers using 6-thio-dG, checkpoint inhibitors and radiation therapy
granted A61KA61K2039/505A61K31/4545
Quick answer
US patent 12097213 (Sequential treatment of cancers using 6-thio-dG, checkpoint inhibitors and radiation therapy) held by The Board of Regents of the University of Texas System expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Sep 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/505, A61K31/4545, A61K31/7076, A61K39/3955